One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Immigration reform in the USA: health must come first
doi : 10.1016/S0140-6736(23)02185-2
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1107
The price and value of therapeutic synergy in liver cancer
David J Pinato, Antonio D’Alessio, Ciro Celsa, Giulia F Manfredi, Claudia A M Fulgenzi
doi : 10.1016/S0140-6736(23)01297-7
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1108-1110
Will the results from the AdaptResponse trial boost CRT use?
Cecilia Linde
doi : 10.1016/S0140-6736(23)01313-2
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1110-1112
Immune recognition of porcine organs transplanted into humans
*Ciara M Shaver, Matthew Bacchetta
doi : 10.1016/S0140-6736(23)01556-8
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1112-1113
Are we there yet? The ongoing journey of cystic fibrosis care
Lucy Perrem, *Felix Ratjen
doi : 10.1016/S0140-6736(23)01727-0
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1113-1115
Long COVID in low-income and middle-income countries: the hidden public health crisis
Waasila Jassat, Luis Felipe Reyes, Daniel Munblit, Janice Caoili, Fernando Bozza, Madiha Hashmi, Michael Edelstein, Cheryl Cohen, Carlos A Alvarez-Moreno, Bin Cao
doi : 10.1016/S0140-6736(23)01685-9
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1115-1117
Offline: We have a decade
Richard Horton
doi : 10.1016/S0140-6736(23)02181-5
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1118
COVAX: the unspent billions
Ann Danaiya Usher
doi : 10.1016/S0140-6736(23)02184-0
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1119-1122
Are we genetically literate enough for global precision health?
Ambroise Wonkam
doi : 10.1016/S0140-6736(23)02046-9
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1123-1124
The expectations trap in medicine
Daniel Marchalik
doi : 10.1016/S0140-6736(23)02047-0
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1125
Anthony Bryceson
Geoff Watts
doi : 10.1016/S0140-6736(23)02048-2
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1126
Community COVID-19 response in WHO's European region
Leonardo Palumbo, Camila A Picchio, Catherine Smallwood, Cristiana Salvi, Gerald Rockenschaub
doi : 10.1016/S0140-6736(23)01671-9
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1127
Arcturus (XBB.1.16) COVID-19 subvariant emergence in Indonesia
Tungki Pratama Umar
doi : 10.1016/S0140-6736(23)01422-8
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1127-1128
Striving to afford free health care in Greece during COVID-19
Christos Tsagkaris, Andreas S Papazoglou, Dimitrios V Moysidis, Stavros P Papadakos, Marios Papadakis
doi : 10.1016/S0140-6736(23)01695-1
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1128-1129
Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity
Maria Elena Flacco, Cecilia Acuti Martellucci, Lamberto Manzoli
doi : 10.1016/S0140-6736(23)01424-1
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1129
Overcoming COVID-19 vaccine hesitancy hurdles
Christos Tsagkaris, Andreas S Papazoglou, Dimitrios V Moysidis, Stavros P Papadakos, Marios Papadakis
doi : 10.1016/S0140-6736(23)01425-3
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1129-1130
Cautionary notes on the COVID-19 re-infection study
Zhi Qu
doi : 10.1016/S0140-6736(23)01426-5
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1130-1131
Natural SARS-CoV-2 infection-induced immune protection against re-infection
Claude Matuchansky
doi : 10.1016/S0140-6736(23)01427-7
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1131
COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection
Ya Bin Zhou, *Zi Gang Xu
doi : 10.1016/S0140-6736(23)01749-X
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1131-1132
COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection – Authors' reply
Christoph Hochmayr, Ursula Kiechl-Kohlendorfer, *Elke Griesmaier
doi : 10.1016/S0140-6736(23)01748-8
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1132
Department of Error
doi : 10.1016/S0140-6736(23)02043-3
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1132
Department of Error
doi : 10.1016/S0140-6736(23)02044-5
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1132
Department of Error
doi : 10.1016/S0140-6736(23)02045-7
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1132
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
Shukui Qin*, Stephen L Chan*, Shanzhi Gu, Yuxian Bai, Zhenggang Ren, Xiaoyan Lin, Zhendong Chen, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Liang, Ying Cheng, Jianping Xiong, Hong Ren, Fang Yang, Wei Li, Yajin Chen, Yong Zeng, Alexander Sultanbaev, Monika Pazgan-Simon, Margaryta Pisetska, Davide Melisi, Dmitriy Ponomarenko, Yurii Osypchuk, Ivan Sinielnikov, Tsai-Sheng Yang, Xiao Liang, Chunxia Chen, Linna Wang, Ann-Lii Cheng†, Ahmed Kaseb†, Arndt Vogel†, for the CARES-310 Study Group
doi : 10.1016/S0140-6736(23)00961-3
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1133-1146
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
Bruce L Wilkoff, Gerasimos Filippatos, Christophe Leclercq, Michael R Gold, Ahmad S Hersi, Kengo Kusano, Wilfried Mullens, G Michael Felker, Charan Kantipudi, Mikhael F El-Chami, Vidal Essebag, Bertrand Pierre, Francois Philippon, Francisco Perez-Gil, Eugene S Chung, Juan Sotomonte, Stanley Tung, Balbir Singh, Babak Bozorgnia, Satish Goel, Hans Holger Ebert, Niraj Varma, Kara J Quan, Fiorella Salerno, Bart Gerritse, Janelle van Wel, Daniel E Schaber, Dedra H Fagan, David Birnie, for the AdaptResponse investigators
doi : 10.1016/S0140-6736(23)00912-1
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1147-1157
Immune response after pig-to-human kidney xenotransplantation: a multimodal phenotyping study
Alexandre Loupy*, Valentin Goutaudier*, Alessia Giarraputo*, Fariza Mezine, Erwan Morgand, Blaise Robin, Karen Khalil, Sapna Mehta, Brendan Keating, Amy Dandro, Anaïs Certain, Pierre-Louis Tharaux, Navneet Narula, Renaud Tissier, Sébastien Giraud, Thierry Hauet, Harvey I Pass, Aurélie Sannier, Ming Wu, Adam Griesemer, David Ayares, Vasishta Tatapudi, Jeffrey Stern, Carmen Lefaucheur, Patrick Bruneval, Massimo Mangiola, Robert A Montgomery
doi : 10.1016/S0140-6736(23)01349-1
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1158-1169
Pulmonary embolism with thrombus-in-transit across a patent foramen ovale
John W Ostrominski*, Christine J Wang*, Umberto Campia, Jean M Connors, Dirk J Varelmann, Domagoj Mladinov, Mohamed Keshk, Hicham Skali
doi : 10.1016/S0140-6736(23)01854-8
Volume 402, Issue 10408, 30 September–6 October 2023, Page 1170
CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis
Jennifer L Taylor-Cousar, Paul D Robinson, Michal Shteinberg, Damian G Downey
doi : 10.1016/S0140-6736(23)01609-4
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1171-1184
The future of cystic fibrosis treatment: from disease mechanisms to novel therapeutic approaches
Simon Y Graeber, Marcus A Mall
doi : 10.1016/S0140-6736(23)01608-2
Volume 402, Issue 10408, 30 September–6 October 2023, Pages 1185-1198
